Back to trial detailsIntake questionnaire
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
Applying to Velocity Clinical Research Providence · East Greenwich, Rhode Island
Answer a few short questions to share with the research team.
0 of 4 answered